Apogee Therapeutics, Inc. Common Stock (APGE) — Financial Flexibility Index
Apogee Therapeutics, Inc. Common Stock (APGE) has a Financial Flexibility Index of -0.51x as of June 2026. Free cash flow of $-71.37 Million (operating CF $-71.38 Million minus capex $6.00K) represents -1% of total liabilities ($141.21 Million). Check Apogee Therapeutics, Inc. Common Stock tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Apogee Therapeutics, Inc. Common Stock Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Apogee Therapeutics, Inc. Common Stock across 4 annual periods. For the full cash flow conversion analysis, see Apogee Therapeutics, Inc. Common Stock cash flow conversion.
Annual Financial Flexibility Index for Apogee Therapeutics, Inc. Common Stock (2022–2025)
Year-by-year free cash flow to debt coverage for Apogee Therapeutics, Inc. Common Stock. Explore Apogee Therapeutics, Inc. Common Stock cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.69x | $-222.30 Million | $-227.45 Million | $33.25 Million | ▼ -46.1% |
| 2024 | -4.58x | $-170.02 Million | $-171.17 Million | $37.16 Million | ▼ -31.8% |
| 2023 | -3.47x | $-74.59 Million | $-74.76 Million | $21.49 Million | ▼ -110.9% |
| 2022 | -1.65x | $-16.43 Million | $-16.43 Million | $9.98 Million | — |